Planned enrollment increased by 145 participants
Before: 700 participants (planned). After: 845 participants (planned).
Study sponsor: Madrigal Pharmaceuticals, Inc. · MDGL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 700 participants (planned). After: 845 participants (planned).